• Nachrichtendetail
• 

11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	SANOFI SA INHABER EO 2	920657	Xetra	95,900	30.07.24 15:53:59	-0,020	-0,02%	95,510	96,660	96,300	95,920
	REGENERON PHARMAC.DL-,001	881535	Frankfurt	990,200	30.07.24 08:18:13	-6,000	-0,60%	1.002,500	1.009,500	990,200	996,200